17.09.2014
- Merck Serono, the biopharmaceutical division of Merck KGaA has decided to discontinue the clinical development program of its investigational MUC1 antigen-specific cancer...
02.09.2014
- The first half suggests that 2014 will be a record year for M&A in pharmaceuticals, with the size of deals having increased substantially over prior years. In 2011, the deal volume...
01.09.2014
- German neurologists are standing by currently prescribed interferon-based multiple sclerosis treatments, despite a warning issued by the Federal Institute for Drugs and Medical...
29.07.2014
- The German chemical industry has come out squarely in favor of the controversial US-European trade agreement Transatlantic Trade and Investment Partnership (TTIP). While many...
25.07.2014
- Merck Serono, the biopharmaceuticals arm of Germany's Merck KgaA, is extending by two years its 10-year R&D cooperation with San Raffaele University & Research Hospital for...
21.07.2014
- The German chemical industry has come out squarely in favor of the controversial US-European trade agreement Transatlantic Trade and Investment Partnership (TTIP).While many across...
17.07.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA has appointed Luciano Rossetti as executive vice president and global head of research & development with...
04.07.2014
- Bayer HealthCare said it plans to keep consumer brands such as Dr. Scholl's and Coppertone it picked up in its $14 billion buy of US Merck's non-prescription drugs business in May...
